Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,484.9
-44.9 (-1.78%)

 

  • STI Straits Times Index
    2,484.9
    -44.9 (-1.78%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,572.6
    -31.1 (-1.94%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,458.1
    -137.2 (-0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,368.0
    58.0 (1.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,195.4
    485.4 (2.24%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,006.2
    -143.4 (-2.78%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,314.7M
  • Value: 1,707.3M
  • Rise: 132
  • Fall: 217
  • Unch: 460

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl1.010+0.110
Moya Asia0.072+0.013
Genting Sing0.725-0.010
Singtel2.450-0.030
ThaiBev0.610-0.030
Rex Intl0.181-0.001
Arion Ent0.006-0.004
Hyphens Pharma0.585+0.020
CapitaMall Trust1.850-0.040
Spackman0.009+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MERUS B V MERUS N.V.
Updated on 31 Jul 2020 (End of trading day)
Last (USD): 13.690 Change: -0.340 High: 13.880 Remarks: -
Change (%): -2.42 Low: 13.245
Open 13.750 Yesterday's Close 14.03
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 32,233 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.89904 Trailing EPS (USD) e -1.89904 NAV (USD) b 3.9456
PE a - Trailing PE f - Price / NAV b 3.4697
Dividend (USD) d - Cash In Hand (USD) g 5.7091 Issued & Paid-up Shares c 29,041,500
Dividend Yield (%) d - Price / Cash In Hand g 2.398 Treasury Shares h -
Market Cap (M) 397.578 Enterprise Value (M) 188.421
Piotroski F Score 0 Exchange Code MRUS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 70.25 Free Float (%) 66.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 19 May 2016.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MERUS B V NASDAQ 397.578 - - 3.4697 -
Industry Biotechnology NASDAQ 2,874.853 436.404 6455.431 9.1119 0.656
Local Peer AMGEN INC NASDAQ 143,301.751 18.274 19.633 13.4442 2.394
Local Peer GILEAD SCIENCES INC NASDAQ 87,216.346 16.193 28.299 - 3.658
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 71,121.762 33.615 31.203 5.8618 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 70,523.344 59.928 56.713 - -
Local Peer ILLUMINA INC NASDAQ 56,177.520 56.065 59.636 12.1203 -
Local Peer BIOGEN INC NASDAQ 43,486.998 7.385 7.337 3.8454 -
Local Peer SEATTLE GENETICS INC NASDAQ 28,930.481 - - - -
Local Peer MODERNA INC NASDAQ 28,811.858 - - 17.5588 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,463.041 9.343 26.549 2.1412 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,666.081 - 190.043 6.6871 -
Local Peer INCYTE CORPORATION NASDAQ 21,467.757 48.036 - 11.0788 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 19,556.385 - - - -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), VAXCYTE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), EPIZYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), REGENXBIO INC (NASDAQ), NANTKWEST INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), COMPUGEN (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), PASSAGE BIO INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), VAXART INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AKOUOS INC (NASDAQ), AVROBIO INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), ATHERSYS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), NEXTCURE INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CHIASMA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), INMUNE BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), OTONOMY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ORGENESIS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), VACCINEX INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ARAVIVE INC (NASDAQ), RESTORBIO INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), OCUGEN INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), COHBAR INC (NASDAQ), SOLIGENIX INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CURIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), PRECIPIO INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOCARDIA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 125,839.680 46.904 43.441 14.5506 0.957
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 217,444.670 189.153 189.153 15.2053 -
Global Peer SINO BIOPHARM HKEx 188,726.000 61.489 62.052 5.4472 0.531
Global Peer BEIGENE HKEx 151,013.200 - - 6.9281 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,832.068 107.011 75.156 - -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 31,740.914 - - 10.6413 -
Global Peer 3SBIO HKEx 23,862.182 21.612 21.612 2.2164 -
Global Peer HAOHAI BIOTEC HKEx 18,414.820 43.800 43.800 3.1308 0.740
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), IBIO INC (NYSE American), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), IMMUTEP LTD (ASX), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), ANTEOTECH LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CT ENTERPRISE (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), REGENEUS LTD (ASX), REGENT PACIFIC (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), HAO WEN H-OLD (HKEx), HAO WEN H-NEW (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.080
+0.59 %
10 Days -+0.150
+1.11 %
20 Days --1.780
-11.51 %
Medium Term Return 3 Months -+0.220
+1.63 %
6 Months --3.230
-19.09 %
1 Year --1.680
-10.93 %
Long Term Return 2 Years --6.720
-32.93 %
3 Years --2.040
-12.97 %
Annualised Return Annualised --
-4.52 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 10.186 - 20.950 Change From 1 Year Low +3.504 % Change From 1 Year Low (%) +34.40
Change From 1 Year High -7.260 % Change From 1 Year High (%) -34.65
2 Years Range 10.186 - 22.460 Change From 2 Years Low +3.504 % Change From 2 Years Low (%) +34.40
Change From 2 Years High -8.770 % Change From 2 Years High (%) -39.05
5 Years Range 7.255 - 33.634 Change From 5 Years Low +6.435 % Change From 5 Years Low (%) +88.70
Change From 5 Years High -19.944 % Change From 5 Years High (%) -59.30
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands.

Historical Price Data

Date Open High Low Close Volume VWAP
31 Jul 2020 13.750 13.880 13.245 13.690 32,233 -
30 Jul 2020 13.350 14.100 13.200 14.030 44,304 -
29 Jul 2020 13.900 14.065 12.955 13.310 110,905 -
28 Jul 2020 13.730 14.140 13.500 13.810 40,693 -
27 Jul 2020 13.980 14.200 13.225 13.610 46,288 -
24 Jul 2020 13.590 13.590 12.870 13.480 55,119 -
23 Jul 2020 13.500 13.738 13.360 13.640 40,026 -
22 Jul 2020 13.600 13.730 13.440 13.600 22,752 -
21 Jul 2020 13.540 13.930 13.345 13.610 76,964 -
20 Jul 2020 13.760 14.020 13.310 13.540 67,049 -
17 Jul 2020 14.300 14.410 13.520 13.680 47,228 -
16 Jul 2020 13.870 14.440 13.740 14.160 38,831 -
15 Jul 2020 14.250 14.340 13.780 14.110 47,118 -
14 Jul 2020 13.670 14.240 13.270 14.140 78,144 -
13 Jul 2020 14.640 14.770 13.530 13.660 73,359 -
10 Jul 2020 15.420 15.420 14.150 14.380 71,460 -
09 Jul 2020 15.300 15.730 14.980 15.430 59,537 -
08 Jul 2020 15.500 15.550 15.115 15.250 32,776 -
07 Jul 2020 15.370 15.830 15.280 15.500 20,863 -
06 Jul 2020 16.120 16.120 15.120 15.470 34,890 -
02 Jul 2020 16.090 16.141 15.680 15.820 18,703 -
01 Jul 2020 16.080 16.280 15.790 16.000 31,615 -
Summary
Current 2 Weeks
(20 Jul 2020 to 31 Jul 2020)
13.760 14.200 12.870 13.690 536,333 -
Previous 2 Weeks
(06 Jul 2020 to 17 Jul 2020)
16.120 16.120 12.870 13.680 504,206 -
4 Weeks from
(05 Jun 2020 to 02 Jul 2020)
16.280 16.280 12.870 15.820 2,157,047 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.